Quantification of Bax/Bcl-2 ratios in peripheral blood lymphocytes, monocytes and granulocytes and their relation to susceptibility to anti-Fas (anti-CD95)-induced apoptosis

H. J. van der Vliet, P. C. Wever, F. N. van Diepen, S. L. Yong, I. J. ten Berge

Research output: Contribution to journalArticleAcademicpeer-review

30 Citations (Scopus)

Abstract

Neutrophils have the shortest half-life among circulating leucocytes and rapidly undergo apoptosis in vitro. The homologous Bcl-2 and Bax proteins have opposing effects, with Bcl-2 extending cellular survival and Bax promoting cell death following an apoptotic stimulus. We determined Bcl-2 to Bax expression ratios in peripheral blood lymphocytes, monocytes and granulocytes and related them to the susceptibility of these cells to anti-Fas (anti-CD95)-induced apoptosis. Here, we show that Bax/Bcl-2 ratios are high in granulocytes and relatively low in monocytes and lymphocytes. Furthermore, we show a relation between this ratio in the different leucocyte subsets and their susceptibility to anti-Fas-induced apoptosis, with granulocytes showing the highest susceptibility, followed by monocytes and lymphocytes. It is concluded that the balance between Bcl-2 and Bax forms an apoptotic rheostat, which seems to determine sensitivity to apoptosis
Original languageEnglish
Pages (from-to)324-328
Number of pages5
JournalClinical and experimental immunology
Volume110
Issue number2
DOIs
Publication statusPublished - Nov 1997

Keywords

  • Adult
  • Apoptosis/immunology
  • Cells, Cultured
  • Flow Cytometry
  • Granulocytes/immunology
  • Humans
  • Lymphocytes/immunology
  • Middle Aged
  • Monocytes/immunology
  • Proto-Oncogene Proteins c-bcl-2/analysis
  • Proto-Oncogene Proteins/analysis
  • bcl-2-Associated X Protein
  • fas Receptor/immunology

Cite this